George Fox
Obstetrics · Smyrna, TNNPI 1568412393
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.2% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $823, 3.5 times the $237 reported in 2019.
Across 147 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$580
- Astellas Pharma US Inc$490
- Organon$295
- Sage Therapeutics, LLC$242
- Channel Medsystems, Inc.$174
- Sumitomo Pharma America, Inc.$114
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,70493%
- Education$1967%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $580 |
| Astellas Pharma US Inc | 16 | $490 |
| Organon | 15 | $295 |
| Sage Therapeutics, LLC | 12 | $242 |
| Channel Medsystems, Inc. | 2 | $174 |
| Sumitomo Pharma America, Inc. | 5 | $114 |
| Therapeuticsmd, Inc. | 8 | $112 |
| Shield Therapeutics Inc | 5 | $108 |
| Mayne Pharma Commercial LLC | 7 | $104 |
| Millicent US Inc | 5 | $86 |
| Exeltis, USA Inc. | 5 | $83 |
| Coopersurgical, Inc. | 5 | $81 |
| Roche Diagnostics Corporation | 3 | $60 |
| Daiichi Sankyo Inc. | 3 | $58 |
| Supernus Pharmaceuticals, Inc. | 2 | $49 |
| Mylan Pharmaceuticals Inc. | 3 | $47 |
| Bayer | 2 | $44 |
| Medtronic | 2 | $31 |
| Novo Nordisk | 1 | $20 |
| Pfizer | 1 | $19 |
| Cepheid | 1 | $18 |
| Scynexis, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Aspira Women's Health Inc | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Boston Scientific | 1 | $12 |
How this compares
$2,900 in reported general payments places this provider in the 80th percentile of 26 obstetrics providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 15 | $904 |
| Estradiol | 14 | $293 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Smyrna
- Erin SaundersKnoxville$6K
- Kreg JonsonChattanooga$6K
- Jerrie Haney-WeaverKnoxville$4K
- Jessica RuffinMemphis$3K
- Kenneth O KelleyKnoxville$3K
- Deidrea GrandberryMemphis$3K
- Kendra HayslettMartin$3K
- Stephanie DallasNashville$3K
- Corey McGlothanMemphis$2K
- Heather WherryMemphis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.